NIH OAR-ORWH Women & HIV Symposium: Considerations from Across the Lifespan
Event Description
Saturday, February 18
1:30 p.m.–2:30 p.m. PT
4:30 p.m.–5:30 p.m. ET
The National Institutes of Health (NIH) Office of AIDS Research (OAR) and Office of Research on Women’s Health (ORWH) are co-sponsoring a symposium at the 13th International Workshop on HIV & Women 2023 in Seattle, Washington. This symposium launches a new collaboration between NIH OAR and ORWH to advance HIV research for cisgender women, transgender women, and people assigned female at birth.
Co-chairs:
Leslie Marshall, Ph.D., OAR
Elizabeth Barr, Ph.D., ORWH
Goals
The symposium objectives are to:
- Increase awareness of key issues related to women and HIV from across the lifespan
- Discuss research priorities for HIV prevention, treatment, and cure related to women, aging, and multimorbidity
- Support women in science careers to reach their full potential
Send questions and feedback via email: WomenandHIV@od.nih.gov
Panelists
- Dvora Joseph Davey, M.P.H., Ph.D., presenter
David Geffen School of Medicine, Fielding School of Public Health
University of California, Los Angeles - Krista Dong, M.D.
Ragon Institute of MGH, MIT and Harvard - Lauren F. Collins, M.D., M.Sc., presenter
Emory University School of Medicine
Grady Ponce de Leon Center - Catherine Godfrey, M.D., FRACP
Office of the U.S. Global AIDS Coordinator and Global Health Diplomacy
U.S. Department of State - Noelle M. St. Vil, Ph.D., M.S.W, LMSW, presenter
University at Buffalo School of Social Work - Jamila Stockman, Ph.D., M.P.H.
University of California, San Diego, School of Medicine
More Information
Email WomenandHIV@od.nih.gov with questions and feedback, or to sign up for updates on the HIV and women collaboration.
Learn more about ORWH at nih.gov/women.
More Information About the OAR-ORWH Collaboration to Advance Research on HIV and Women
OAR’s signature program on HIV and women is a partnership with ORWH. The program aims to promote the NIH vision for women’s health where all women – including transgender women and individuals assigned female at birth – receive evidence-based, gender-affirming, tailored HIV prevention, care, and treatment. This program also supports women in science careers to reach their full potential.
OAR and ORWH recently launched an NIH HIV and Women Working Group to identify gaps and priorities at the intersection of women’s health and HIV.
This page last reviewed on February 9, 2023